Stock scanner
Ready-made scans
Fastest expected revenue growth under $2BCheap and profitableDividend payersNear their 52-week highBeaten down, finances improvingReporting this week
Filters
5,450 US-listed companies, filtered by valuation, profitability, growth, analysts' forecasts and momentum. Prices are from the October 9 close; company figures refresh weekly.
This data is 11 days old: the nightly update hasn't run since October 10.
The scanner turns your question into filters, and the results come straight from the data. The filters it chose show below, to check or change. You get 3 free questions a month.
5,450 companies match
| Company | Mkt cap | Price | P/E | EV/Sales | P/B | Yield | Net margin | ROIC | Rev growth | 1Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ACIUAC Immune S.A. | $254M | $2.50 | loss | 10.7 | 5.8 | 0.0% | −246% | −86.6% | −39.5% | −29.6% |
| FATEFate Therapeutics, Inc. | $254M | $2.18 | loss | 45.8 | 1.7 | 0.0% | −1941% | −57.5% | −23.4% | +32.9% |
| LXEOLexeo Therapeutics, Inc. Common Stock | $254M | $3.23 | loss | — | 1.2 | 0.0% | — | −39.3% | — | −60.8% |
| CURVTorrid Holdings Inc. | $253M | $2.54 | loss | 0.7 | neg. eq. | 0.0% | −0.9% | 5.9% | −11.2% | +69.3% |
| BRTBRT Apartments Corp. | $252M | $13.41 | loss | 7.5 | 1.5 | 7.5% | −13.1% | 1.8% | 3.0% | −8.8% |
| MPTIM-tron Industries, Inc. | $252M | $70.63 | 24.0 | 2.7 | 2.4 | 0.0% | 16.3% | 7.1% | 11.8% | +31.8% |
| XPERXperi Inc. | $251M | $5.21 | loss | 0.5 | 1.4 | 0.0% | −7.1% | −2.1% | −3.9% | −17.2% |
| SHMDSCHMID Group N.V. Class A Ordinary Shares | $251M | $3.82 | loss | 3.2 | neg. eq. | 0.0% | −113% | −0.8% | 5.7% | +45.2% |
| PROFProfound Medical Corp. | $251M | $6.90 | loss | 11.6 | 5.1 | 0.0% | −171% | −60.5% | 62.2% | +17.5% |
| GBFHGBank Financial Holdings Inc. | $250M | $17.31 | 13.4 | n/a | 1.4 | 0.0% | 17.4% | n/a | 18.4% | −56.3% |
| INRInfinity Natural Resources, Inc. | $250M | $13.34 | 4.4 | — | 0.3 | 0.0% | 11.7% | 10.7% | 75.4% | +5.2% |
| TLSITriSalus Life Sciences, Inc. | $250M | $4.06 | loss | 5.3 | 36.1 | 0.0% | −62.6% | −59.2% | 25.2% | −6.0% |
| EPRXEupraxia Pharmaceuticals Inc. | $250M | $7.46 | loss | — | 3.8 | 0.0% | — | −43.1% | — | +22.9% |
| IHRTiHeartMedia, Inc. | $250M | $1.92 | loss | 1.5 | neg. eq. | 0.0% | −7.2% | 0.4% | 3.1% | −25.9% |
| AMRNAmarin Corporation plc | $249M | $12.03 | loss | 0.6 | 0.6 | 0.0% | −14.6% | −7.2% | −15.1% | −34.0% |
| UXINUxin Limited | $248M | $1.13 | loss | 0.8 | — | 0.0% | −10.0% | −16.8% | 90.9% | −64.6% |
| QTTBQ32 Bio Inc. | $248M | $8.34 | 3.0 | 2.7 | 1.1 | 0.0% | 62.9% | 19.3% | — | +134% |
| CNDTConduent Incorporated | $248M | $1.60 | loss | 0.3 | 0.4 | 0.0% | −8.2% | −0.3% | −10.3% | −35.5% |
| LCTXLineage Cell Therapeutics, Inc. | $248M | $0.99 | loss | 16.3 | 4.1 | 0.0% | −247% | −23.3% | 19.9% | −40.1% |
| IMMRImmersion Corporation | $247M | $7.43 | 21.9 | 0.2 | 0.8 | 3.6% | 0.6% | 1.5% | 4.1% | +8.8% |
| ALITAlight, Inc. | $247M | $9.36 | loss | 0.9 | 0.2 | 17.1% | −90.9% | 27.3% | −3.5% | −84.6% |
| DRDBRoman DBDR Acquisition Corp. II | $247M | $10.72 | 60.9 | — | 1.0 | 0.0% | — | −1.6% | — | +3.8% |
| EFSIEagle Financial Services, Inc. | $246M | $45.53 | 13.2 | n/a | 1.3 | 2.7% | 15.8% | n/a | 18.4% | +26.5% |
| EVIEVI Industries, Inc. | $246M | $19.12 | 34.8 | 0.7 | 1.6 | 1.7% | 1.7% | 4.6% | 14.6% | −31.5% |
| RMBIRichmond Mutual Bancorporation, Inc. | $246M | $15.32 | 12.4 | n/a | 1.0 | 3.9% | 13.0% | n/a | 5.3% | +12.6% |
| TGTredegar Corporation | $245M | $7.03 | 7.3 | 0.4 | 1.1 | 0.0% | 4.3% | 9.3% | 44.8% | −7.1% |
| SARSaratoga Investment Corp. | $245M | $15.03 | 15.0 | 7.7 | 0.6 | 21.6% | 16.6% | 1.4% | 0.1% | −30.4% |
| RCDReady Capital Corporation Notes -15.12.29 | $245M | $21.98 | loss | n/a | 0.2 | 12.2% | −136% | n/a | 1108% | −9.5% |
| ZUMZZumiez Inc. | $244M | $14.48 | 18.1 | 0.5 | 0.8 | 0.0% | 1.4% | 2.4% | 3.6% | −24.4% |
| VOGXVogenx Inc. | $244M | $17.56 | — | — | — | — | — | — | — | +35.1% |
| NEGGNewegg Commerce, Inc. | $243M | $11.58 | 25.9 | 0.2 | 1.3 | 0.0% | 0.7% | 2.2% | 4.7% | −74.9% |
| GLSIGreenwich LifeSciences, Inc. | $243M | $16.53 | loss | — | 77.5 | 0.0% | — | −702% | — | +55.2% |
| JACKJack in the Box Inc. | $242M | $12.70 | 7.3 | 2.3 | neg. eq. | 0.0% | 2.8% | 7.0% | −6.7% | −26.8% |
| LFCRLifecore Biomedical, Inc. | $242M | $6.45 | loss | 3.1 | 15.1 | 0.0% | −30.4% | −1.2% | 0.5% | −0.8% |
| MSBMesabi Trust | $242M | $18.42 | 37.2 | 18.8 | 13.7 | 4.8% | 54.5% | 37.4% | −87.5% | −39.9% |
| YSGYatsen Holding Limited | $242M | $2.58 | loss | 0.3 | 0.6 | 0.0% | −4.6% | −9.7% | 20.9% | −63.9% |
| CMTVCommunity Bancorp | $242M | $43.20 | 13.1 | n/a | — | 2.9% | 27.0% | n/a | 7.7% | +90.7% |
| BLNDBlend Labs, Inc. | $241M | $1.00 | loss | 1.7 | 2.5 | 0.0% | −0.4% | −13.6% | −10.3% | −68.6% |
| ASLEAerSale Corporation | $240M | $5.08 | loss | 1.4 | 0.6 | 0.0% | −0.7% | 0.1% | −13.4% | −31.4% |
| PLAYDave & Buster's Entertainment, Inc. | $240M | $6.90 | loss | 1.8 | 2.7 | 0.0% | −4.3% | 1.2% | −1.5% | −59.1% |
| HQIHireQuest, Inc. | $240M | $17.20 | 29.2 | 7.9 | 3.4 | 1.4% | 27.1% | 11.2% | −7.5% | +107% |
| PEBKPeoples Bancorp of North Carolina, Inc. | $239M | $43.78 | 14.3 | n/a | 1.4 | 2.3% | 18.1% | n/a | 11.9% | +51.9% |
| BIOABioAge Labs Inc. | $239M | $6.34 | loss | 16.2 | 0.8 | 0.0% | −912% | −28.1% | 168% | +18.5% |
| SAAQSpace Asset Acquisition Corp. Class A Ordinary Shares | $238M | $10.08 | — | — | — | 0.0% | — | −0.2% | — | +1.7% |
| IPXGInflection Point Acquisition Corp. VII | $238M | $10.07 | — | — | — | — | — | — | — | +2.7% |
| PDYNPalladyne AI Corp. | $238M | $5.04 | loss | 18.1 | 3.3 | 0.0% | −255% | −45.1% | 172% | −39.2% |
| QLEPQuantum Leap Acquisition Corp | $238M | $10.05 | — | — | — | 0.0% | — | — | — | +1.0% |
| MGNXMacroGenics, Inc. | $238M | $3.74 | loss | 0.9 | 5.5 | 0.0% | −8.7% | −2.4% | 2.3% | +121% |
| UTMDUtah Medical Products, Inc. | $237M | $74.54 | 22.7 | 6.6 | 1.9 | 1.7% | 29.0% | 6.8% | −7.0% | +21.5% |
| EAFGrafTech International Ltd. | $237M | $9.11 | loss | 2.5 | neg. eq. | 0.0% | −34.6% | −9.8% | 0.9% | −50.1% |
Showing 3,551–3,600 of 5,450
A blank means a figure isn't reported or doesn't mean anything for that company: there's no P/E for a company losing money, no EV/Sales for a bank, no P/B when a company owes more than it owns. A filter on that figure leaves the company out. Growth compares the last twelve months with the twelve before. Figures describe the companies; they aren't advice to buy or sell anything.